EC Healthcare

As of March 31, 2026, EC Healthcare carries a market capitalization of 540.61M, placing it among publicly traded companies globally. Its enterprise value stands at 1.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

EC Healthcare's next confirmed earnings release is scheduled for November 26, 2026.

As of March 31, 2026, EC Healthcare has 1.18B shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, EC Healthcare maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, EC Healthcare's stock has declined approximately 18.46% over the past 52 weeks. The 50-day moving average sits at 0.49, while the 200-day moving average is 0.48.

As of March 31, 2026, EC Healthcare holds 988.66M in cash and equivalents against 1.26B in total debt, resulting in a net debt position of -165.99M. Total book value stands at 1.38B, with working capital of -103.27M providing operational flexibility.